Incyte Serves up Information
Executive Summary
Incyte's strategy for generating near-term revenues tapped into the research core of the business; it would sell information it needed to create for its own purposes anyway. By the end of 1994, Incyte's annual report reflected the retreat from drug development, focusing attention instead on the company's efforts to build and commercialize "a computerized encyclopedia, or database, of human genes and their use."